Genomics is bringing in a new wave of money from an unlikely group of investors — health systems. More providers are ...
Genomics reported a Q4 EPS loss of $(0.40), missing estimates, while revenue declined 10% year over year. Analysts lowered price targets amid profitability concerns.
Genomics company 10x and Harvard University have agreed to resolve a patent lawsuit against 10x's rival Vizgen four days into ...
Biomedical engineers at Duke University have demonstrated a promising new approach that could be used to treat a rare and ...
SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO)(the “Company”) today announced that it will effect a reverse stock split of its issued and outstanding common ...
CircleDNA powers blockchain-based identity verification with Humanity Protocol, valued at US $1.1bn after latest fundraisePrenetics invests $1.5M ...
BioSkryb Genomics, a Durham company focused on single-cell and ultra-low input multiomics, has introduced a new service called ResolveSEQ MRD, which allows more detailed classification and ...
Dante Genomics, a global leader in AI-driven genomic analysis, has expanded into Dante Omics AI to reflect its evolution into ...
International collaboration in genomic research is gaining momentum in African countries and is often supported by external ...
PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback